# reload+after+2024-01-23 17:43:39.267595
address1§94 Solaris Avenue
address2§Camana Bay
city§Grand Cayman
zip§KY1-1108
country§Cayman Islands
phone§345-949 4123
website§https://www.beigene.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§BeiGene, Ltd., a biotechnology company, develops and commercializes oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; Tislelizumab to treat various solid tumor and blood cancers; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumor malignancies; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company is also developing Zanubrutinib to treat B-cell malignancies; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Ociperlimab for treating solid tumors, cervical cancer, and NSCLC; Surzebiclimab, BGB-A445, BGB-15025, Lifirafenib, BGB-24714, and BGB-B167 to treat solid tumors; BGB-10188 for treating solid tumors, B-cell lymphoid malignancies, and B-cell malignancies; BGB-11417 to treat R/R chronic lymphocytic leukemia/ small lymphocytic lymphoma, R/R mantle cell lymphoma, Mature B-cell malignancies, Myeloid malignancies, and R/R multiple myeloma; BGB-16673 for B-cell malignancies; and BGB-23339 for Inflammation and immunology. The company has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., Enlivex Therapeutics Ltd., Chime Biologics Limited, and Nanjing Leads Biolabs Co., Ltd. BeiGene, Ltd. was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands.
fullTimeEmployees§10000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. John V. Oyler', 'age': 55, 'title': 'Co-Founder, Executive Chairman & CEO', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 2047812, 'exercisedValue': 0, 'unexercisedValue': 253253760}, {'maxAge': 1, 'name': 'Dr. Xiaobin  Wu Ph.D.', 'age': 61, 'title': 'President & COO', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 1692054, 'exercisedValue': 0, 'unexercisedValue': 9795226}, {'maxAge': 1, 'name': 'Dr. Xiaodong  Wang Ph.D.', 'age': 60, 'title': 'Co- Chairman of Scientific Advisory Board & Non-Executive Director Co-Founder', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 250000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Julia  Wang', 'age': 52, 'title': 'CFO & Principal Accounting Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 964200, 'exercisedValue': 0, 'unexercisedValue': 147488}, {'maxAge': 1, 'name': 'Mr. Wang  Lai Ph.D.', 'age': 46, 'title': 'Global Head of R&D', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 996921, 'exercisedValue': 9132753, 'unexercisedValue': 6572012}, {'maxAge': 1, 'name': 'Ms. Liza  Heapes', 'title': 'Head of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chan  Lee', 'title': 'General Counsel & Senior VP', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Yang  Ji', 'title': 'Chief Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Yan  Qi', 'title': 'Senior VP & Head of Public Affairs - Greater China', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason W. Radford', 'age': 41, 'title': 'Senior Vice President of Strategy & Corporate Development', 'yearBorn': 1982, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§3
compensationRisk§10
shareHolderRightsRisk§6
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.557
priceToSalesTrailing12Months§8.005285
currency§USD
dateShortInterest§1702598400
forwardEps§-8.22
pegRatio§0.15
exchange§NMS
quoteType§EQUITY
shortName§BeiGene, Ltd.
longName§BeiGene, Ltd.
firstTradeDateEpochUtc§1454509800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§fa34b256-867c-3115-a0ac-dc5f85107a4b
gmtOffSetMilliseconds§-18000000
targetHighPrice§359.0
targetLowPrice§196.0
targetMeanPrice§286.55
targetMedianPrice§294.0
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§21
quickRatio§2.75
grossMargins§0.05726
ebitdaMargins§-0.55111
trailingPegRatio§None
